CAS: 65454-13-9 - 3-benzyl-4-methyl-6-(propan-2-yl)morpholine-2,5-dione
Formule :C15H19NO3
InChI :InChI=1S/C15H19NO3/c1-10(2)13-14(17)16(3)12(15(18)19-13)9-11-7-5-4-6-8-11/h4-8,10,12-13H,9H2,1-3H3/t12-,13-/m1/s1
Code InChI :InChIKey=YOKBTBNVNCFOBF-CHWSQXEVSA-N
SMILES :O=C1OC(C(=O)N(C)C1CC=2C=CC=CC2)C(C)C
- Synonymes :
- (3R,6R)-4-Methyl-6-(1-methylethyl)-3-(phenylmethyl)-2,5-morpholinedione
- 2,5-Morpholinedione, 4-methyl-6-(1-methylethyl)-3-(phenylmethyl)-
- 2,5-Morpholinedione, 4-methyl-6-(1-methylethyl)-3-(phenylmethyl)-, (3R,6R)-
- 2,5-Morpholinedione, 4-methyl-6-(1-methylethyl)-3-(phenylmethyl)-, (3R-cis)-
- 4-Methyl-6-(1-Methylethyl)-3-Phenylmethylperhydro-1,4-Oxazine-2,5-Dione
- Lateritin
- Lateritine
Marque | Informations sur le produit | Degré de pureté | Gamme de prix | Livraison estimée |
---|---|---|---|---|
Lateritin REF : 8R-CL0178CAS : 65454-13-9 | 90.16% | À demander | mar 12 Nov 24 | |
(3S,6R)-Lateritin REF : 3D-QCA45413CAS : 65454-13-9 | Min. 95% | À demander | ven 27 Déc 24 | |
Lateritin REF : TM-T25635CAS : 65454-13-9 | 99.23% | 241,00 €~2.322,00 € | jeu 16 Jan 25 |
Lateritin
Ref: 8R-CL0178
1mg | À demander | ||
5mg | À demander |
(3S,6R)-Lateritin
Ref: 3D-QCA45413
25mg | À demander | ||
50mg | À demander | ||
100mg | À demander |
Lateritin
Ref: TM-T25635
1mg | 241,00 € | ||
5mg | 596,00 € | ||
10mg | 848,00 € | ||
25mg | 1.272,00 € | ||
50mg | 1.718,00 € | ||
100mg | 2.322,00 € | ||
1mL*10mM (DMSO) | 527,00 € |